Rachel Curtis Gravesen
Director/Board Member bei CESSATECH A/S
Profil
Rachel Curtis Gravesen is currently a Director at Cessatech A since 2022.
Prior to this, she worked as a Communications Manager at Novo Nordisk A.
From 2011 to 2019, she served as Senior VP-Investor Relations & Communications at Genmab A.
She also worked as Vice President-Investor Relations at Pharmaceutical Development Center.
Ms. Gravesen is a graduate of St. John's College, Cambridge and City University London.
Aktive Positionen von Rachel Curtis Gravesen
| Unternehmen | Position | Beginn |
|---|---|---|
| CESSATECH A/S | Director/Board Member | 17.03.2022 |
Ehemalige bekannte Positionen von Rachel Curtis Gravesen
| Unternehmen | Position | Ende |
|---|---|---|
| GENMAB A/S | Investor Relations Contact | 11.03.2019 |
| NOVO NORDISK A/S | Public Communications Contact | - |
Pharmaceutical Development Center
 Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Public Communications Contact | - |
Ausbildung von Rachel Curtis Gravesen
| St. John's College, Cambridge | Graduate Degree |
| City University London | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| NOVO NORDISK A/S | Health Technology |
| GENMAB A/S | Health Technology |
| CESSATECH A/S | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Pharmaceutical Development Center
Pharmaceutical Development Center Miscellaneous Commercial ServicesCommercial Services Part of AAIPharma, Inc., Pharmaceutical Development Center researches and develops pharmaceutical products. The private company is based in Charlotte, NC. Pharmaceutical Development Center was acquired by AAIPharma, Inc. on July 31, 2001. | Commercial Services |
